Page Title
Drug Development Pipeline
TB Alliance
Status
Pre-clinicalTherapeutic Approach
Anti-Infective
This program will identify and test potential treatments for infections caused by Mycobacterium abscessus (M. abscessus) and Mycobacterium avium complex (MAC), two types of nontuberculous mycobacteria (NTM).
Status
Laboratory studies to identify and test these compounds are underway.
Sponsor
This program is sponsored by TB Alliance, in partnership with Johns Hopkins University, and is partially funded by the Cystic Fibrosis Foundation.

CONTACT THE CLINICAL TRIAL NAVIGATOR
Get personalized assistance and answers to your clinical trial questions.
Learn MoreSign up for clinical trial alerts
Get email updates about clinical trials that matter to you.
Explore clinical trials
Be a part of the movement transforming the future of cystic fibrosis treatment.
Learn More